Search

everythinglearnresearchcommunity

for

Search:↓

Nurses are exposed to chemotherapy drugs, risking health issues like hair loss, so protective gear and monitoring are needed.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

BFNB could be a promising treatment for hair growth.

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

Frontal fibrosing alopecia can occur in men and may be linked to immune triggers like vaccines.

Rb-bFGF improves hair transplant results and patient satisfaction with fewer complications.

Frontal Fibrosing Alopecia in men is often missed and can come with symptoms like facial bumps and hair loss on eyebrows and limbs.

Bicalutamide may help treat female pattern hair loss.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

Frontal fibrosing alopecia significantly affects men, often causing hair loss in eyebrows, beard, and sideburns.

FFA in young women is often missed, and no single treatment works best.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Bicalutamide improves hair density in women safely.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatments.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Proper niche formation in Drosophila requires Slit-Robo signaling for cell migration.